IBRX ImmunityBio, Inc.

Healthcare

$7.92+9.70%ClosedMarket Cap: $8.30B

As of 2026-05-26

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.05	$518.3M	2
Sun Dec 31	$0.48	$1.20B	2
Mon Dec 31	$1.09	$2.22B	1
Tue Dec 31	$1.94	$3.74B	1